Davide Ciardiello, Medical Oncologist at the Division of Gastrointestinal and Neuroendocrine Tumors at the European Institute of Oncology, shared on LinkedIn:
“Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial”
Authors: Silvia Marsoni, Clara Montagut, Filippo Pietrantonio, Andrea Sartore-Bianchi, Luca Lazzari, Francesca Bergamo, Maria Giulia Zampino, Noelia Tarazona, Mario Mandalà, Stefano Tamberi, Elena Elez, Cristina Santos Vivas, Paolo Luraghi, Michele Prisciandaro, Federica Tosi, Davide Ciardiello, Joana Vidal, Victor Seguì, Michele Palazzo, Giulia Maddalena, Katia Bencardino, Ida Taglialatela, Marta Guix, Eliana Rulli, Valentina Vettore, Federica Morano, Claudio Isella, Giovanni Crisafulli, Giorgio Patelli, Enzo Medico, Alberto Bardelli, Andrés Cervantes, Valter Torri, Josep Tabernero, Salvatore Siena, Sara Lonard
Read the Full Article
Mario Mandalà, Director of Medical Oncology at S.M. Misericordia Hospital and Associate Professor of Medical Oncology at the University of Perugia, added:
“Happy to be part of this outstanding project.
Thank Silvia Marsoni and Sara Lonardi, for your leadership.
Congratulations to all co-authors.
Great academic independent study.”
Other articles featuring Davide Ciardiello and Mario Mandalà on OncoDaily.